The common signs of prostatitis include experiencing burning sensation while passing urine, frequent urination and not being ...

Dr. Jianjun ZOU, General Manager and CEO of Junshi Biosciences, said, “The approval of toripalimab by MHRA marks another significant milestone for toripalimab in Europe, not onl ...

Evan Saugstad’s series discussing his journey with prostate cancer continues.

Bacteria are helping to enhance the body's immune system's ability to attack cancer cells. This phenomenon is paving the way ...

The Douglas County Sheriff's Office said a necropsy for the dog revealed evidence of severe malnutrition and infection in the ...

“Establishing a routine can help train your bladder to hold urine longer and may reduce urgency at night,” she explains. If ...

Platinum-based chemotherapy has long been the standard treatment for metastatic bladder cancer and for muscle-invasive bladder cancer where neoadjuvant ... Since the trend of consolidation is and has ...

‘Please. Kill me now!’ He said to his son one morning. Of course, there was nothing he or any of us could legally do. These ...

Key Takeaways Men’s incontinence is a common issue affecting many individuals globally. Understanding the types and causes ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy ...

Clinical Data: The Phase 2 results demonstrated that bel-sar achieved an 80% tumor control rate (n=8/10 ... immune staining in both treated target and untreated non-target bladder tumors with rapid ...

Perioperative durvalumab has “the potential to transform the standard of care” for patients with muscle-invasive bladder ...